Thierry Paper
Founder bei BIOSYNEX
Vermögen: 2 Mio $ am 31.03.2024
Profil
Thierry Paper founded Biosynex SA in 2005, where he is working as Director, Deputy CEO-Research & Development from 2015.
Mr. Paper also currently works at Chembio Diagnostics, Inc., as Director from 2023, Theradiag SA, as Director from 2022, Biosynex Swiss SA, as Director, Orgenics Ltd., as Marketing Manager from 1990, and Axodev SARL, as Manager.
Mr. Paper received his Masters Business Admin degree from Ecole Nationale des Ponts et Chaussées.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BIOSYNEX SA
3,62% | 31.12.2022 | 389 988 ( 3,62% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Thierry Paper
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOSYNEX | Founder | 15.03.2005 |
| THERADIAG | Director/Board Member | 05.05.2022 |
| CHEMBIO DIAGNOSTICS, INC. | Director/Board Member | 27.04.2023 |
| Axodev SARL | Corporate Officer/Principal | - |
Orgenics Ltd.
 Orgenics Ltd. Medical SpecialtiesHealth Technology Orgenics Ltd. develops medical diagnostic test kits for the diagnosis of infectious diseases. Its products include RapidTest, DoubleCheck, DoubleCheckGold, Clinical Chemistry, Indirect Peroxidase, Point of Care DrugCheck, BioAssay Systems, Microbiology, Veterinary and MediScreen Pipettes. The company was founded in 1982 and is headquartered in Yavne, Israel. | Sales & Marketing | 01.01.1990 |
| Biosynex Swiss SA | Director/Board Member | - |
Ausbildung von Thierry Paper
| Ecole Nationale des Ponts et Chaussées | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Chembio Diagnostics, Inc.
 Chembio Diagnostics, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
Orgenics Ltd.
Orgenics Ltd. Medical SpecialtiesHealth Technology Orgenics Ltd. develops medical diagnostic test kits for the diagnosis of infectious diseases. Its products include RapidTest, DoubleCheck, DoubleCheckGold, Clinical Chemistry, Indirect Peroxidase, Point of Care DrugCheck, BioAssay Systems, Microbiology, Veterinary and MediScreen Pipettes. The company was founded in 1982 and is headquartered in Yavne, Israel. | Health Technology |
Theradiag SA
 Theradiag SA Medical SpecialtiesHealth Technology Theradiag SA engages in the distribution, development, and manufacturing of in vitro diagnostic and theranostics tests. It operates through the following segments: Theranostics and Diagnostics. The Theranostics segment offers solutions for patients treated with anti-tumour necrosis factor alpha. The Diagnostics segment includes products for anti-immunity, genetics, allergy, infectious disease, drug of abuse, other diagnoses, and instrumentation. The company was founded on December 29, 1986 and is headquartered in Croissy-Beaubourg, France. | Health Technology |
| Biosynex SA | |
| Axodev SARL | |
| Biosynex Swiss SA |
